Holen Sie sich die Stockscreener-App
2.68
10.29%
0.25
Handel nachbörslich:
2.75
0.07
+2.61%
Schlusskurs vom Vortag:
$2.43
Offen:
$2.44
24-Stunden-Volumen:
2.70M
Relative Volume:
2.11
Marktkapitalisierung:
$249.57M
Einnahmen:
$34.48M
Nettoeinkommen (Verlust:
$-102.07M
KGV:
-1.8356
EPS:
-1.46
Netto-Cashflow:
$-104.90M
1W Leistung:
+18.58%
1M Leistung:
+48.07%
6M Leistung:
+239.24%
1J Leistung:
+41.80%
1-Tages-Spanne:
$2.40
$2.745
1-Wochen-Bereich:
$2.17
$2.745
52-Wochen-Spanne:
$0.66
$2.9995
Caribou Biosciences Inc Stock (CRBU) Company Profile
Firmenname
Caribou Biosciences Inc
Sektor
Branche
Telefon
510-982-6030
Adresse
2929 7TH STREET, SUITE 105, BERKELEY
Vergleichen Sie CRBU mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRBU
Caribou Biosciences Inc
|
2.68 | 226.29M | 34.48M | -102.07M | -104.90M | -1.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 105.19B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.68 | 60.24B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.86 | 61.82B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
798.94 | 49.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
351.09 | 37.52B | 4.56B | -176.77M | 225.30M | -1.7177 |
Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-11-08 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-10-31 | Eingeleitet | Evercore ISI | Outperform |
| 2023-07-11 | Eingeleitet | Truist | Buy |
| 2022-02-18 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-12-01 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-11-15 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-08-17 | Eingeleitet | BofA Securities | Buy |
| 2021-08-17 | Eingeleitet | Citigroup | Neutral |
| 2021-08-17 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Caribou Biosciences Inc Aktie (CRBU) Neueste Nachrichten
Caribou Biosciences, Inc. $CRBU Shares Sold by Public Employees Retirement System of Ohio - Defense World
Real time social sentiment graph for Caribou Biosciences Inc.Market Growth Summary & Daily Risk Controlled Trade Plans - newser.com
Does Caribou Biosciences Inc. fit your quant trading model2025 Institutional Moves & Growth Focused Stock Pick Reports - newser.com
How to use a screener to detect Caribou Biosciences Inc. breakoutsRate Hike & Community Verified Trade Signals - newser.com
Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Short interest data insights for Caribou Biosciences Inc.July 2025 Analyst Calls & AI Powered Buy and Sell Recommendations - newser.com
Bank of America Securities Sticks to Their Buy Rating for Caribou Biosciences (CRBU) - The Globe and Mail
Combining machine learning predictions for Caribou Biosciences Inc.Trade Signal Summary & Low Risk Entry Point Guides - newser.com
How Caribou Biosciences Inc. stock compares to market leaders2025 Breakouts & Breakdowns & High Conviction Trade Alerts - newser.com
Reversal indicators forming on Caribou Biosciences Inc. stockPortfolio Return Report & Step-by-Step Trade Execution Guides - newser.com
Published on: 2025-10-03 00:57:18 - newser.com
Published on: 2025-10-02 23:00:53 - newser.com
How to monitor Caribou Biosciences Inc. with trend dashboardsJuly 2025 Opening Moves & Pattern Based Trade Signal System - newser.com
CRISPR Therapies Clinical Trial Pipeline Shows Potential - GlobeNewswire
CRISPR Therapies Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight - GlobeNewswire Inc.
BofA Securities Maintains Caribou Biosciences(CRBU.US) With Buy Rating - 富途牛牛
Bronstein, Gewirtz & Grossman, LLC Encourages Caribou Biosciences, Inc. (CRBU) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
HC Wainwright Issues Negative Estimate for CRBU Earnings - Defense World
HC Wainwright Expects Lower Earnings for Caribou Biosciences - MarketBeat
Goldman Sachs Group Inc. Has $751,000 Stock Position in Caribou Biosciences, Inc. $CRBU - Defense World
What is HC Wainwright’s Estimate for CRBU FY2026 Earnings? - Defense World
What is HC Wainwright's Estimate for CRBU FY2026 Earnings? - MarketBeat
Will Caribou Biosciences Inc. continue its uptrendTake Profit & AI Driven Price Forecasts - metal.it
Caribou Biosciences stock rating reiterated by H.C. Wainwright - Investing.com India
Finanzdaten der Caribou Biosciences Inc-Aktie (CRBU)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.05%
4.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):